Mehdi Gasmi, Director at Adverum Biotechnologies, Inc. (ADVM), sold 5,000 shares at $20.02 ($100K) on 2020-05-21, disclosed to the SEC on 2020-05-22.
Scheduled sale ($100k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.01 | 1,401 | $28K | 28.0% |
| 2 | $20.02 | 3,599 | $72K | 72.0% |
| Total | $20.02 avg | 5,000 | $100K | 100% |
| Filing → |
| ADVM | SELL | 2020-06-18 | $563K | — | Filing → |
| ADVM | SELL | 2020-06-17 | $324K | — | Filing → |
| ADVM | SELL | 2020-05-20 | $917K | — | Filing → |